PRAXISforum Enzymes for Industrial Applications 2016

Speakers and Moderator


Mara Bönitz-Dulat, Roche Diagnostics

Mara Bönitz-Dulat
Head of Enzyme Development, Roche Diagnostics, Germany

"Evolution and development of enzymes using with the maximum of goal-orientated methods and industrial procedures to bring biocatalyst to industrial products in order to support biotechnological applications."

Martin Borchert, Novozymes

Martin Borchert

Head of Bioinformatics and Microbe Technology, R&D, Novozymes, Denmark

"While next and 3rd generation DNA sequencing techniques become more and more affordable, customized DNA synthesis became a commodity service, and analytical instruments equip us with increasing accuracy, we have to concentrate our efforts to gain most value of those new technologies and combine them with each other in order to harvest optimal synergy. Failure in doing so will result in too long innovation cycles which ultimately will result in poor product development processes."

Emil Byström, SpinChem

Emil Byström

CEO, SpinChem, Sweden

"Attractive production economy using heterogeneous biocatalysis could now be realized with RBR technology!”

Karim E. Cassimjee, EnginZyme

Karim Cassimjee
CEO, EnginZyme, Sweden

"I believe that the potential of biocatalysis far exceeds the current exploitation. One of the main reasons being the higher cost of use compared to traditional catalysis. The ongoing developments in molecular biotechnology and bioinformatics broaden the scope of possible chemistries. A general immobilization procedure may well be a step towards making biocatalysis the first choice, a sustainable as well as cost effective alternative."

Robert DiCosimo, DuPont Industrial Biosciences

Robert DiCosimo
DuPont Fellow, DuPont Industrial Biosciences, USA

“In certain applications, a customer may require that an enzyme not be engineered for improved properties or performance. The ability to identify a naturally-occurring enzyme that meets these requirements can be challenging, but is often possible through the power of bioinformatics and genome mining.”

Yves Dudal, INOFEA

Yves Dudal

CEO, INOFEA, Switzerland

"The next generation of drugs requires enzyme-mediated precision processing, let’s meet the challenge!"

Andrew Ellis, Biocatalysts

Andrew Ellis
Technical Director, Biocatalysts, United Kingdom

Stephan Freyer, BASF

Stephan Freyer
Head of Bioprocess Development, BASF, Germany

"Process development is key of the innovation chain!"

Harald Gröger, Bielefeld University

Harald Gröger
Chair of Organic Chemistry I, Bielefeld University, Germany

"The combination of different (and complementary) types of catalysts, e.g., chemo- and biocatalysts, in one-pot processes enables a perspective towards the development of efficient production technologies, which avoids cost-, capacity-, and solvent-intensive purification steps of intermediates. One of the challenges in this field is the design of compatible catalyst and reaction systems, which are tolerant against the components being involved in the other reaction steps."

Guido Jach, Phytowelt GreenTechnologies

Guido Jach
CSO, Phytowelt GreenTechnologies, Germany

"Identification of functional enzymes for synthetic biology approaches is still a major challenge. Database integration and bioinformatics are helpful, but still require further improvement, in particular with respect to structural analyses. Functional characterization of enzymes remains to be labour intensive and time consuming limiting step in the development of new systems."

Ulf Menyes, Enzymicals

Ulf Menyes
CEO, Enzymicals, Germany

"An open discussion of scientists from the field of biocatalysis, users in organic synthesis and technologists from the plant engineering is essential to overcome language barriers and technical challenges. Economic and simultaneously sustainable synthesis processes will be mixed chemical and biocatalytic processes over a period of the next 20 years and more."

David Schönauer, SeSaM-Biotech

David Schönauer
CEO, SeSaM-Biotech, Germany

"Blindfolded random enzyme evolution belongs to the past – highly customized solutions employing a broad spectrum of methods and technologies to find the best “amino acid teams” will yield the enzymes that define tomorrow’s medicine and industry."

Julia Schückel, GlycoSpot

Julia Schückel
Research Scientist, GlycoSpot, Denmark

"Our assay will help answer key questions in the enzyme discovery field, such as finding new enzyme activities for industrial processes. The main advantage of our technique is that our substrates are available in four different colours that can be mixed together, which makes it high-throughput, cost-effective and extremely convenient."

Volker Sieber, TU Munich

Volker Sieber
Chair of Chemistry of Biogenic Ressources, TU Munich, Germany

"Only the combination of the best of both worlds - chemical catalysis and enzyme catalysis – will enable the technically and economically viable utilization of biobased resources for chemicals and fuel production."

Lars Wiemann, evoxx technologies

Lars Wiemann
Business Development Manager, evoxx technologies, Germany

"Next to a lack of physical exercise the worldwide increase in obesity and related diseases such as diabetes is mainly caused by an excessive uptake of processed food and especially industrial sugars. The evoxx team is developing novel carbohydrate ingredients for healthy food products."

Joachim von Heimburg, jvhinnovation

Joachim von Heimburg
Founder and Managing Director of jvhinnovation, Switzerland

"The use of enzymes increases effectiveness and efficiency of many industrial processes and products and provides cost savings and environmental benefits. It’s just that nature has no interest in industry. So we humans have to work on enzymes to make them effective and efficient in industrial applications. That’s what we’ll talk about in this conference."






Jetzt Mitglied werden